Aster Capital Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$81.5K Buy
7,362
+7,107
+2,787% +$43.5K 0.02% 507
2026
Q1
$2.49K Buy
+255
New +$1.95K ﹤0.01% 745
2025
Q2
Sell
-1,047
Closed -$13.3K 1485
2025
Q1
$13.3K Sell
1,047
-7,229
-87% -$89.5K ﹤0.01% 1031
2024
Q4
$100K Buy
8,276
+8,183
+8,799% +$99.4K 0.04% 383
2024
Q3
$1.02K Buy
+93
New +$945 ﹤0.01% 1021

Other funds holding REPL

Aster Capital Management's REPL Position: Q2 2026 in Review

Aster Capital Management increased its Replimune Group (REPL) stake by 2,787% in Q2 2026, buying an estimated $43.5K and bringing the position to 7,362 shares worth $81.5K. The position accounts for 0.02% of the portfolio, ranked #507.

Aster Capital Management first reported a position in REPL in Q3 2024 and has held it in 5 quarters since. The position peaked at $100K in Q4 2024. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Aster Capital Management held 7,362 shares of Replimune Group worth $81.5K as of Q2 2026.
  • Aster Capital Management bought 7,107 Replimune Group shares in Q2 2026, an estimated $43.5K.
  • Replimune Group made up 0.02% of Aster Capital Management's portfolio in Q2 2026, its #507 holding.
  • Aster Capital Management first reported a position in Replimune Group in Q3 2024 and has held it in 5 quarters since.
  • Aster Capital Management's Replimune Group position peaked at $100K in Q4 2024.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.